September 28 (SeeNews) - Bulgaria's Financial Supervision Commission said that it has delisted local drug maker Unipharm from its register of public companies.
The regulator did not provide further details in its statement, published late on Thursday.
You can subscribe to our M&A newsletter here
Unipharm shares were delisted from the Bulgarian Stock Exchange last week, after the documents regarding its merger into Sopharma were entered into the commercial register on September 13.
Sopharma absorbed Unipharm under a deal envisaging the conversion of each Unipharm share into 0.957502 Sopharma shares.
Unipharm shares last traded on the BSE in May at 4.0 levs apiece. The price translates into market capitalisation of 24 million levs ($14.3 million/12.3 million euro).
(1 euro = 1.95583 levs)